Understanding Patient Preferences Regarding the Important Determinants of Breast Cancer Treatment: A Narrative Scoping Review

Abstract

Objective: Conventionally, optimal treatment strategies for breast cancer have been largely determined by physicians, with a scant understanding of patients' treatment values and preferences. Incorporating patient preferences in the decision-making process for breast cancer treatment is gaining recognition and can potentially improve treatment outcomes and compliance. This scoping review aims to synthesize evidence on the key determinants that are most valued by breast cancer patients when deciding on their treatment options. Methods: We searched three electronic databases (PubMed/MEDLINE, SCOPUS, and CINAHL Plus) utilizing a systematic scoping review method. Two reviewers independently screened, applied inclusion criteria, reviewed, and synthesized findings. A mixedmethod narrative approach combining the inductive thematic analysis and content analysis methodologies was used to synthesize and summarize the findings. Results: The review included 22 studies, leading to the conceptualization of 5 overarching themes and 17 sub-themes. Among these, the most frequently cited theme was treatment benefits, followed by treatment-related process, treatment-related risk, quality of life, and cost of treatment. Women with breast cancer highly value treatments that offer good effectiveness, prolong survival, prevent recurrence, and maintain quality of life. Patient concerns include treatment-related side effects, safety, the risk of secondary cancer, and direct or indirect out-of-pocket costs. Additionally, patients also consider treatment duration, mode of administration, physician recommendation, and treatment availability and accessibility when deciding on their preferred treatment. Conclusion:The evidence synthesized in this review offers insights into refining breast cancer treatment strategies to align more closely with patient values. Recognizing and integrating patient perspectives in breast cancer care could potentially lead to improved treatment outcomes, enhanced patient compliance, and more personalized care. Healthcare professionals are encouraged to incorporate these key determinants in their treatment decision-making processes, aiming to deliver a patient-centered care that aligns with the unique preferences and values of each patient.Plain Language Summary: Breast cancer is a significant health concern, and treatment decisions have traditionally driven by physicians, often without due consideration for patients' preferences in their treatment choices. This scoping review aimed to explore and summarize what matters most to breast cancer patients when deciding on their treatment options. We found five main themes that were important to patients:(1) Effectiveness: Patients highly value treatments that are effective in fighting cancer, prolonging survival, and preventing recurrence.(2) Treatment-related process: The length of treatment and availability of different therapies influenced patients' choices. Patients trust their doctors' expertise but also value being involved in the decision-making process to have t...

Exploring the Important Determinants Shaping Treatment Preferences: Qualitative Insights into Breast Cancer Patient Experiences and Perspectives in New Zealand

“…The interview guide was developed from a review of the literature and discussion among the experts in oncology and patient preference. 17 Throughout the interview process, the guide was modified iteratively based on insights gained from earlier participants to ensure that the additional relevant attributes were adequately addressed in subsequent interviews. A total of six FGDs and five IDIs were conducted.…”

Impact of Systemic Treatments on Outcomes and Quality of Life in Patients with RAS-Positive Stage IV Colorectal Cancer: A Systematic Review

“…While some studies report improvements or stable QoL scores post-treatment, the presence of significant adverse events, as noted in the comparison of complication rates between treatment arms, underscores the need for a balanced approach to treatment planning. This necessitates a careful evaluation of the potential benefits of treatment against the risk of adverse effects, emphasizing the importance of patient-centered care in the management of stage IV cancer, as it was proven as the most efficient method by recent studies [42,43].…”

Assessment of patient perceptions of counselling on oral antineoplastic agents by a dedicated cancer services pharmacist in an outpatient cancer clinic

“…The recent explosion in the development and availability of oral antineoplastic agents (OAAs) has caused an overall paradigm shift in cancer treatment [ 1 , 2 ]. Oncologists are increasingly prioritising patient preference and quality of life by choosing treatments that maximise convenience and flexibility, as well as clinical outcomes [ 3 ]. Previous studies have shown that patients display a preference for oral home-based over intravenous (IV) treatment, when efficacy is not compromised.…”